Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
about
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyMultifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variantsA characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.Investigation of peripheral neuropathyMultifocal motor neuropathy with conduction block: a study of 24 patientsTreatment of chronic inflammatory demyelinating polyneuropathy.Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders.Multifocal motor neuropathy: response to human immune globulin.Clinical spectrum of chronic acquired demyelinating polyneuropathies.Use of human intravenous immunoglobulin in lower motor neuron syndromesThe effect of treatment upon temporal dispersion in IvIg responsive multifocal motor neuropathyA practical definition of conduction block in IvIg responsive multifocal motor neuropathyAutoimmune neuropathies.Multifocal motor neuropathy: current concepts and controversies.Axon loss is an important determinant of weakness in multifocal motor neuropathy.Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion.Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy.Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.Diagnosis of acute neuropathies.Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy.The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathyFailure of activation of spinal motoneurones after muscle fatigue in healthy subjects studied by transcranial magnetic stimulation.Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies.Increased probability of repetitive spinal motoneuron activation by transcranial magnetic stimulation after muscle fatigue in healthy subjects.Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness.Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.Entrapment in anti myelin-associated glycoprotein neuropathy.Low-rate nerve stimulation during regional ischemia in the diagnosis of muscle glycogenosis
P2860
Q24187418-516DF009-2BA3-45FA-8750-582743369597Q24200228-1907C47F-7C9C-40F1-8D86-5C02C0205B59Q24241391-4787BB3C-8116-4A3C-8693-337A5E72996BQ24246618-E77E7D8C-6E0A-4FFC-8EFF-6C04C6660A67Q28390264-3BBE9B3A-A261-43AE-BAE3-771F26C614F4Q33590978-7110671F-F52F-4CBE-A314-61792C7AA552Q33733816-F96BCCFD-EF31-4E58-A1F7-433BAA4E0CE2Q33734400-E2E4B9A2-A5F8-4CF9-99DE-973C2B655B16Q33996087-661F7C0E-B64E-4A98-8255-0FEE2FB10BE6Q34044159-2A4C28B6-1DE4-46A6-93AE-B1B3064C3CFAQ34062007-C595D482-2078-4CF2-843F-FAD3C24794FEQ34251202-EE7D7D07-B0C8-46AA-91E1-5249FAD68A12Q35452109-4B5B3B75-0BB8-4FFD-8D56-2E2973E588FAQ35489630-F565C369-53D3-4EFD-A325-FCEAD01D5C92Q35489932-2E7642DA-7629-497E-BB70-2919CB796AC8Q35677692-35AC155F-C5AB-42DD-BD5D-2DE41FFB2F9DQ36072147-B5B13B8D-B50F-4373-8DBB-2156219307FBQ36142106-02F2B095-B4A1-45D7-835C-921291500201Q36227135-F49F1DC7-F168-4E4A-B46D-6C043A03B901Q36317538-3EBA172D-7E90-4008-87DF-600C4094BE17Q36880697-3EB6768C-7545-4BB4-A839-ED986E23AC8DQ37000439-B734943B-2F8B-4B3A-BF6A-43CCD9F8DB02Q37893214-7D7C3E06-0A3A-456F-866F-74F32D628711Q37959252-98BA39C8-A37D-4B84-857F-10FB5786F79AQ40792349-B4F874F3-F085-47C7-8F6C-EA9A881136EDQ40906180-108F8A64-3986-4A28-8DBB-0CBF5530A135Q41663344-7FEA049D-2871-4164-B4C1-2374757F30B5Q44489952-47652AC6-7E95-4192-8EB9-699468C9F734Q46163603-BBA38B32-25F8-44B3-8AE5-D3B91DBD9857Q47783162-092AC1F4-C0C5-4D83-B66E-F61753A771E9Q48428384-8B282BE8-96FF-4BF6-8AD4-0444B3997297Q49125609-2BC6097B-E699-407A-AAE3-C19DA71167A8Q51755402-4F778596-1405-4B1A-AFE7-63F674574F26Q57243941-C279B205-1A88-4B89-9A31-3737C91C4EF7
P2860
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@en
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@nl
type
label
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@en
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@nl
prefLabel
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@en
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@nl
P2093
P356
P1433
P1476
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?
@en
P2093
D S Younger
R E Lovelace
W Trojaborg
P304
P356
10.1212/WNL.42.3.497
P407
P433
P577
1992-03-01T00:00:00Z